2-phenoxyphenol has been researched along with triclosan in 3 studies
*Triclosan: A diphenyl ether derivative used in cosmetics and toilet soaps as an antiseptic. It has some bacteriostatic and fungistatic action. [MeSH]
*Triclosan: A diphenyl ether derivative used in cosmetics and toilet soaps as an antiseptic. It has some bacteriostatic and fungistatic action. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, G; Johnson, F; Novichenok, P; Simmerling, C; Sivaraman, S; Sullivan, TJ; Tonge, PJ | 1 |
| am Ende, C; Bowen, RA; England, K; Kisker, C; Knudson, DL; Knudson, SE; Lu, H; Luckner, S; Marlenee, NL; Reddy, BG; Slayden, RA; Tonge, PJ; Truglio, JJ | 1 |
| Baxter, MV; Bommineni, GR; Chang, A; Khanna, A; Kisker, C; Pan, P; Schiebel, J; Sotriffer, CA; Tonge, PJ; Yu, W | 1 |
3 other study(ies) available for 2-phenoxyphenol and triclosan
| Article | Year |
|---|---|
Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
Topics: Anti-Bacterial Agents; Bacteria; Crystallography, X-Ray; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Microbial Sensitivity Tests; Models, Molecular; Mutation; NAD; Oxidoreductases; Protein Binding; Structure-Activity Relationship; Thermodynamics; Triclosan | 2004 |
Slow-onset inhibition of the FabI enoyl reductase from francisella tularensis: residence time and in vivo activity.
Topics: Animals; Anti-Bacterial Agents; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Fatty Acid Synthase, Type II; Fatty Acid Synthesis Inhibitors; Female; Francisella tularensis; Mice; Mice, Inbred ICR; Phenyl Ethers; Structure-Activity Relationship; Triclosan; Tularemia | 2009 |
Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complex.
Topics: Catalysis; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Design; Enoyl-(Acyl-Carrier Protein) Reductase (NADPH, B-Specific); Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Fatty Acids; Hydrogen Bonding; Models, Molecular; Protein Binding; Protein Conformation; Staphylococcus aureus; Thermodynamics; Time Factors | 2013 |